Literature DB >> 25845947

Are There Modifiable Risk Factors for Hospital Readmission After Total Hip Arthroplasty in a US Healthcare System?

Elizabeth W Paxton1, Maria C S Inacio2, Jasvinder A Singh3, Rebecca Love2, Stefano A Bini4, Robert S Namba5.   

Abstract

BACKGROUND: Although total hip arthroplasty (THA) is a successful procedure, 4% to 11% of patients who undergo THA are readmitted to the hospital. Prior studies have reported rates and risk factors of THA readmission but have been limited to single-center samples, administrative claims data, or Medicare patients. As a result, hospital readmission risk factors for a large proportion of patients undergoing THA are not fully understood. QUESTIONS/PURPOSES: (1) What is the incidence of hospital readmissions after primary THA and the reasons for readmission? (2) What are the risk factors for hospital readmissions in a large, integrated healthcare system using current perioperative care protocols?
METHODS: The Kaiser Permanente (KP) Total Joint Replacement Registry (TJRR) was used to identify all patients with primary unilateral THAs registered between January 1, 2009, and December 31, 2011. The KPTJRR's voluntary participation is 95%. A logistic regression model was used to study the relationship of risk factors (including patient, clinical, and system-related) and the likelihood of 30-day readmission. Readmissions were identified using electronic health and claims records to capture readmissions within and outside the system. Odds ratio (OR) and 95% confidence intervals (CIs) were calculated. Of the 12,030 patients undergoing primary THAs included in the study, 59% (n = 7093) were women and average patient age was 66.5 years (± 10.7).
RESULTS: There were 436 (3.6%) patients with hospital readmissions within 30 days of the index procedure. The most common reasons for readmission were infection and inflammatory reaction resulting from internal joint prosthetic (International Classification of Diseases, 9(th) Revision, Clinical Modification [ICD-9-CM] 996.66, 7.0%); other postoperative infection (ICD-9-CM 998:59, 5.5%); unspecified septicemia (ICD-9-CM 038.9, 4.9%); and dislocation of a prosthetic joint (ICD-9-CM 996.42, 4.7%). In adjusted models, the following factors were associated with an increased likelihood of 30-day readmission: medical complications (OR, 2.80; 95% CI, 1.59-4.93); discharge to facilities other than home (OR, 1.89; 95% CI, 1.39-2.58); length of stay of 5 or more days (OR, 1.80; 95% CI, 1.22-2.65) versus 3 days; morbid obesity (OR, 1.74; 95% CI, 1.25-2.43); surgeries performed by high-volume surgeons compared with medium volume (OR, 1.53; 95% CI, 1.14-2.08); procedures at lower-volume (OR, 1.41; 95% CI, 1.07-1.85) and medium-volume hospitals (OR, 1.81; 95% CI, 1.20-2.72) compared with high-volume ones; sex (men: OR, 1.51; 95% CI, 1.18-1.92); obesity (OR, 1.32; 95% CI, 1.02-1.72); race (black: OR, 1.26; 95% CI, 1.02-1.57); increasing age (OR, 1.03; 95% CI, 1.01-1.04); and certain comorbidities (pulmonary circulation disease, chronic pulmonary disease, hypothyroidism, and psychoses).
CONCLUSIONS: The 30-day hospital readmission rate after primary THA was 3.6%. Modifiable factors, including obesity, comorbidities, medical complications, and system-related factors (hospital), have the potential to be addressed by improving the health of patients before this elective procedure, patient and family education and planning, and with the development of high-volume centers of excellence. Nonmodifiable factors such as age, sex, and race can be used to establish patient and family expectations regarding risk of readmission after THA. Contrary to other studies and the finding of increased hospital volume associated with lower risk of readmission, higher volume surgeons had a higher risk of patient readmission, which may be attributable to the referral patterns in our organization. LEVEL OF EVIDENCE: Level III, therapeutic study.

Entities:  

Mesh:

Year:  2015        PMID: 25845947      PMCID: PMC4586234          DOI: 10.1007/s11999-015-4278-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  31 in total

1.  The role of anesthesia in surgical mortality.

Authors:  R D DRIPPS; A LAMONT; J E ECKENHOFF
Journal:  JAMA       Date:  1961-10-21       Impact factor: 56.272

Review 2.  Total hip and total knee replacement (1).

Authors:  W H Harris; C B Sledge
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

3.  Total joint arthroplasty readmission rates and reasons for 30-day hospital readmission.

Authors:  Victoria Avram; Danielle Petruccelli; Mitch Winemaker; Justin de Beer
Journal:  J Arthroplasty       Date:  2013-08-28       Impact factor: 4.757

4.  Risk factors, causes, and the economic implications of unplanned readmissions following total hip arthroplasty.

Authors:  Rutledge Carter Clement; Peter B Derman; Danielle S Graham; Rebecca M Speck; David N Flynn; Lawrence Scott Levin; Lee A Fleisher
Journal:  J Arthroplasty       Date:  2013-08-13       Impact factor: 4.757

5.  Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors.

Authors:  Benjamin Zmistowski; Camilo Restrepo; Jordan Hess; Darius Adibi; Soltan Cangoz; Javad Parvizi
Journal:  J Bone Joint Surg Am       Date:  2013-10-16       Impact factor: 5.284

6.  The validity of using administrative claims data in total joint arthroplasty outcomes research.

Authors:  Kevin J Bozic; Vanessa W Chiu; Steven K Takemoto; Jordan N Greenbaum; Thomas M Smith; Seth A Jerabek; Daniel J Berry
Journal:  J Arthroplasty       Date:  2010-06-08       Impact factor: 4.757

7.  Age and obesity are risk factors for adverse events after total hip arthroplasty.

Authors:  James I Huddleston; Yun Wang; Carlos Uquillas; James H Herndon; William J Maloney
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

8.  The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery.

Authors:  Kevin J Bozic; Judith Maselli; Penelope S Pekow; Peter K Lindenauer; Thomas P Vail; Andrew D Auerbach
Journal:  J Bone Joint Surg Am       Date:  2010-11-17       Impact factor: 5.284

9.  Incidence and short-term outcomes of primary and revision hip replacement in the United States.

Authors:  Chunliu Zhan; Ronald Kaczmarek; Nilsa Loyo-Berrios; Judith Sangl; Roselie A Bright
Journal:  J Bone Joint Surg Am       Date:  2007-03       Impact factor: 5.284

10.  Readmission rates in the state of Florida: a reflection of quality?

Authors:  Carlos J Lavernia; Jesus M Villa; David A Iacobelli
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

View more
  36 in total

1.  Unplanned hospital readmission following total joint arthroplasty.

Authors:  Hasham M Alvi; Rachel E Mednick; Francis Lovecchio; Kevin D Hardt; David W Manning
Journal:  Ann Transl Med       Date:  2015-11

2.  Association of Pain on Hospital Discharge with the Risk of 30-Day Readmission in Patients with Total Hip and Knee Replacement.

Authors:  Ickpyo Hong; Jordan R Westra; James S Goodwin; Amol Karmarkar; Yong-Fang Kuo; Kenneth J Ottenbacher
Journal:  J Arthroplasty       Date:  2020-07-03       Impact factor: 4.757

3.  Functional Gain and Pain Relief After Total Joint Replacement According to Obesity Status.

Authors:  Wenjun Li; David C Ayers; Courtland G Lewis; Thomas R Bowen; Jeroan J Allison; Patricia D Franklin
Journal:  J Bone Joint Surg Am       Date:  2017-07-19       Impact factor: 5.284

Review 4.  Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach.

Authors:  Benedict Morath; Tanja Mayer; Alexander Francesco Josef Send; Torsten Hoppe-Tichy; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Br J Clin Pharmacol       Date:  2017-06-14       Impact factor: 4.335

5.  Are Readmissions After THA Preventable?

Authors:  Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera
Journal:  Clin Orthop Relat Res       Date:  2016-11-11       Impact factor: 4.176

6.  CORR Insights(®): Periprosthetic Joint Infection in Hip Arthroplasty: Is There an Association Between Infection and Bearing Surface Type?

Authors:  Sumon Nandi
Journal:  Clin Orthop Relat Res       Date:  2016-07-05       Impact factor: 4.176

7.  National Incidence of Patient Safety Indicators in the Total Hip Arthroplasty Population.

Authors:  Joseph E Tanenbaum; Derrick M Knapik; Glenn D Wera; Steven J Fitzgerald
Journal:  J Arthroplasty       Date:  2017-04-12       Impact factor: 4.757

8.  Predictors and Cost of Readmission in Total Knee Arthroplasty.

Authors:  Kenneth L Urish; Yongmei Qin; Benjamin Y Li; Tudor Borza; Michael Sessine; Peter Kirk; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus; Bruce L Jacobs
Journal:  J Arthroplasty       Date:  2018-04-17       Impact factor: 4.757

9.  Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Brent J Morris; David Mannino; Andrew Hoellein; Ryan P Donegan; Leslie J Crofford
Journal:  Semin Arthritis Rheum       Date:  2016-08-24       Impact factor: 5.532

10.  Perspectives of Orthopedic Surgeons on Racial/Ethnic Disparities in Care.

Authors:  Muyibat A Adelani; Mary I O'Connor
Journal:  J Racial Ethn Health Disparities       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.